期刊文献+

大鼠血浆中硫醚-雷贝拉唑浓度测定方法的建立和验证 被引量:1

Establishment and validation of a method for determination of rabeprazole thioether in rat plasma
原文传递
导出
摘要 目的:建立高效液相色谱-质谱法(HPLC-MS)测定大鼠血浆中硫醚-雷贝拉唑浓度。方法:血浆样品以地西泮为内标,乙腈沉淀蛋白处理,采用HPLC-MS法检测。色谱柱为InertsilODS-3(4.6 mm×150 mm,5μm),流动相为乙腈-5mmol·L-1醋酸铵溶液(65∶35),流速为0.7 ml·min-1。用ESI离子源,正离子检测模式,选择监测质荷比(m/z)为344.2(硫醚-雷贝拉唑)和285.1(内标)的离子峰。结果:硫醚-雷贝拉唑在2~800 ng·ml-1浓度范围内线性关系良好,最低定量限为2ng·ml-1。提取回收率为102.9%~109.3%,日内、日间精密度分别小于3.9%和6.4%。结论:本方法专属性强,灵敏度高,简便易行,可用于雷贝拉唑大鼠体内药动学的研究。 OBJECTIVE To establish HPLC-MS method for determination of rabeprazole thioether in rat plasma.METHODS Diazepam was used as an internal standard and acetonitrile as the extraction solvent.Rabeprazole thioether and diazepam in plasma by HPLC-MS assay were separated on an Inertsil ODS3(4.6 mm×150 mm,5μm)column,eluted with mobile phase of acetonitrile-5 mmol·L-1 ammonium acetate water solution(65∶35),and a flow rate of 0.7 ml·min-1.MS system with an electrospray ionization(ESI)source was used as the detector and was operated in a positive ion mode.Selected ion monitoring(SIM)was performed and the m/z of ions selected for quantification were 344.2(rabeprazole thioether)and 285.1(internal standard).RESULTS The calibration curve of rabeprazole thioether was linear over the concentration range of 2-800 ng·ml-1.The lower limit of quantitation was 2 ng·ml-1.The extraction recovery was 102.9%-109.3%,the intra and inter day precisions were less than 3.9% and 6.4%.CONCLUSION This method was specificity,sensitive,convenient and can be used for pharmacokinetic study of rabeprazole in rat plasma.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2015年第7期601-605,共5页 Chinese Journal of Hospital Pharmacy
关键词 硫醚-雷贝拉唑 血浆 HPLC-MS法 rabeprazole thioether plasma HPLC-MS
  • 相关文献

参考文献5

二级参考文献29

  • 1张勇,陈笑艳,顾琦,钟大放.液相色谱-串联质谱法测定人体血浆中雷贝拉唑[J].质谱学报,2003,24(z1):107-108. 被引量:1
  • 2徐戎,顾世芬,陈笑艳,钟大放,陈汇.雷贝拉唑肠溶制剂的人体相对生物利用度[J].中国医院药学杂志,2005,25(12):1128-1131. 被引量:6
  • 3陈建青,戴莉,李立,丁黎,沈建平,张银娣.雷贝拉唑钠肠溶片人体生物等效性研究[J].海峡药学,2007,19(6):96-99. 被引量:4
  • 4Kawakami Y, Akahane T, Yamaguchi M, et al. ln vitro activities of rabeprazole, a novel proton pump inhibitor and its thioether derivative alone and combination with other antimicrobials against recent clinical isolates of Helieobacter pylori[J]. Antimicrob Agent Chemother, 2000, 44: 458.
  • 5McColl K, Kennerley P. Proton pump inhibitors-differences emerge in hepatic metabolism[J]. Dig Liver Dis, 2002, 34:461 -467.
  • 6Richardson P, Hawkey CJ, Stack WA. Proton pump inhibitors[J]. Drugs, 1998, 56: 307.
  • 7Langty HD, Markham A. Rabeprazole: a review of its use in acid - related gastrointestinal disorders[J]. Drugs, 1999, 58:725 - 742.
  • 8Carswell CI, Goa KL. Rabeprazole: an update of its use in acid - related disorders[J]. Drugs, 2001, 61:2 327.
  • 9Tytgat GNJ. Short comings of the first - generation proton pump inhibitors [J]. Eur J Gastroenterol Hapatol, 2001, 131 s29.
  • 10Mehta DR, Maseeh A. Prevention of acid aspiration during surgery for cancer using I. V rabeprazole[J]. J Clin Oncol, 2005, 23:8 275.

共引文献31

同被引文献12

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部